Rosetta Genomics (Nasdaq: ROSG), announced that data from studies demonstrating the clinical utility of two of the Company's miRview products ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE